The #NephJC editorial on PATH-BP is now live on Kidney Medicine!
Nice work by Momen Abbasi, Priya John, Cristina Popa, helmed by Jade and Jamie.
This week, we will discuss the 2025 KDIGO IgAN guidelines. which the shift from supportive care to structured, evidence-based therapy
This week, we will discuss an old dilemma in nephrology. To restrict or supplement the proteins? Premise: advanced CKD and dialysis.
This week, we will discuss the use of creating chimeras to induce immune tolerance and its potential to decrease or eliminate the need for immunosuppression in kidney transplant recipients.
The #NephJC editorial on PATH-BP is now live on Kidney Medicine!
Nice work by Momen Abbasi, Priya John, Cristina Popa, helmed by Jade and Jamie.
Read the #TenTweetNephJC summary of the ADMIRAL study, examining how dd-cfDNA monitoring may help us manage our patients with renal transplants.
1. Does transplant medicine have a new blood test that is better than creatinine?
— Nephrology Jrnl Club (@NephJC) July 1, 2022
Aye aye ADMIRAL 🫡
Join us as we recap last week's #NephJC chat on this edition of #TenTweetNephJC brought to you by @jamiekwillows and @michaelturk6 pic.twitter.com/gAS70VKG8i
Did you miss the TESTING reboot discussion? No worries, we have you covered here:
Welcome to #TenTweetNephJC where we will be discussing the largest randomized, placebo controlled trial of steroid treatment in IgA nephropathy patients.
— Nephrology Jrnl Club (@NephJC) June 21, 2022
✳️ 10 tweets #NephJC catch-up ✳️ pic.twitter.com/kRdt91F8gq
Check out the beautiful VA for TESTING trial by NSMC Intern Hamze Rage
After CHIP we discussed CHAP. In case you missed it, we have you covered here:
Welcome to #TenTweetNephJC
— Nephrology Jrnl Club (@NephJC) June 1, 2022
✳️ Last week's #NephJC in 10 tweets ✳️
Did you miss the latest CHAPter of #NephJC? Join us as we catch you up on the Chronic Hypertension in Pregnancy trial -- the CHAP chat!https://t.co/zdjwgONpt1 pic.twitter.com/4RK5HKulC6
The SSASS trial editorial is up in Kidney Medicine! Have a read.
Nice work by Yoshinosuke Shimamura, Michael Turk, Md Abdul Qader and Shweta Shah!
What the hell is CHIP and why do I need to know about it?
Check out this rapid summary by the talented and creative Tiffany Caza!
Did you miss the last #NephJC? Check out this #TenTweetNephJC to catch up! pic.twitter.com/7oT34h2vzx
— Nephrology Jrnl Club (@NephJC) May 24, 2022
Here is a visual take at “Should we treat mild chronic hypertension during pregnancy?” by Dr. Anand Chellappan
NSMC intern Mohamed Ibrahim created a beautiful visual abstract which simplifies the findings of CHIP study.
The discussion of the BASICS trial is up at Kidney Medicine. Great work by Mythri Shankar, Carlo Trinidad, and Elliot Tannor. Check it out here.
With guidelines as big as the latest ISPD whopper you can’t #TenTweetNephJC it - but check out the alternative NephJC summary tweetorial with some take home points below.
Wrapping up this chapter of #NephJC with a tweetorial 🧵of take home messages on PD peritonitis, after two great chats regarding the ISPD peritonitis guideline update👇https://t.co/VieQSo0b5C
— Nephrology Jrnl Club (@NephJC) May 2, 2022
A detailed guideline like this deserves not one but two Visual Abstracts and the NSMC team has done justice to it. Here are two amazing VAs by Momen Abbasi and Priya John.
Want to learn more about the latest in using plasma exchange in ANCA-associated vasculitis? (if you’re a nephrologist, of course you do!)
Check out this rapid summary below!
✳️ #TenTweetNephJC ✳️
— Nephrology Jrnl Club (@NephJC) April 8, 2022
👉 where we catch you up on the week's #NephJC chat in 10 tweets
The topic at hand was Plasma Exchange and Vasculitis: the infamous debate of to PLEX or not to PLEX in AAV
Check out this thread to see if you change your mind on this comPLEX topic 👇 pic.twitter.com/PvW0C0O9R9